Cargando…

P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL

Detalles Bibliográficos
Autores principales: Gerds, Aaron T., Grunwald, Michael, Oh, Stephen, Braunstein, Evan, Xue, Zhenyi, Bhatt, Valkal, Yu, Jingbo, Mesa, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431471/
http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5
_version_ 1785091210699866112
author Gerds, Aaron T.
Grunwald, Michael
Oh, Stephen
Braunstein, Evan
Xue, Zhenyi
Bhatt, Valkal
Yu, Jingbo
Mesa, Ruben
author_facet Gerds, Aaron T.
Grunwald, Michael
Oh, Stephen
Braunstein, Evan
Xue, Zhenyi
Bhatt, Valkal
Yu, Jingbo
Mesa, Ruben
author_sort Gerds, Aaron T.
collection PubMed
description
format Online
Article
Text
id pubmed-10431471
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104314712023-08-17 P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL Gerds, Aaron T. Grunwald, Michael Oh, Stephen Braunstein, Evan Xue, Zhenyi Bhatt, Valkal Yu, Jingbo Mesa, Ruben Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431471/ http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Gerds, Aaron T.
Grunwald, Michael
Oh, Stephen
Braunstein, Evan
Xue, Zhenyi
Bhatt, Valkal
Yu, Jingbo
Mesa, Ruben
P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title_full P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title_fullStr P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title_full_unstemmed P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title_short P1032: CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB (RUX) AFTER HYDROXYUREA (HU): A LONGITUDINAL ANALYSIS FROM REVEAL
title_sort p1032: characteristics and clinical outcomes in patients (pts) with polycythemia vera (pv) receiving ruxolitinib (rux) after hydroxyurea (hu): a longitudinal analysis from reveal
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431471/
http://dx.doi.org/10.1097/01.HS9.0000971024.48080.f5
work_keys_str_mv AT gerdsaaront p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT grunwaldmichael p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT ohstephen p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT braunsteinevan p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT xuezhenyi p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT bhattvalkal p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT yujingbo p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal
AT mesaruben p1032characteristicsandclinicaloutcomesinpatientsptswithpolycythemiaverapvreceivingruxolitinibruxafterhydroxyureahualongitudinalanalysisfromreveal